(S)-3,4-DCPG manufacturers
- (S)-3,4-DCPG
-
- $113.00
-
2026-05-11
- CAS:201730-11-2
- Purity:
- Supply Ability: 10g
|
| | (S)-3,4-DCPG Basic information |
| | (S)-3,4-DCPG Chemical Properties |
| Boiling point | 531.0±50.0 °C(Predicted) | | density | 1.634±0.06 g/cm3(Predicted) | | storage temp. | Desiccate at RT | | solubility | DMF: 25 mg/ml; DMSO: 20 mg/ml; Ethanol: 33 mg/ml; PBS (pH 7.2): 10 mg/ml | | pka | 1.59±0.10(Predicted) | | form | Powder | | color | White to off-white | | Water Solubility | Soluble to 100 mM in water | | InChI | InChI=1S/C10H9NO6/c11-7(10(16)17)4-1-2-5(8(12)13)6(3-4)9(14)15/h1-3,7H,11H2,(H,12,13)(H,14,15)(H,16,17)/t7-/m0/s1 | | InChIKey | IJVMOGKBEVRBPP-ZETCQYMHSA-N | | SMILES | C1(C(O)=O)=CC=C([C@H](N)C(O)=O)C=C1C(O)=O |
| | (S)-3,4-DCPG Usage And Synthesis |
| Uses | (S)-3,4-DCPG is a potent and selective mGluR-8a agonist. | | Biological Activity | Potent, selective mGlu 8a agonist (EC 50 = 31 nM). Displays > 100-fold selectivity over mGlu 1-7 and displays little or no activity at NMDA and kainate receptors. Increases c-Fos expression in stress-related brain areas following systemic administration in mice in vivo . Also potent anticonvulsant in mice in vivo . | | IC 50 | hmGluR8a: 31 nM (EC50) | | storage | Desiccate at RT |
| | (S)-3,4-DCPG Preparation Products And Raw materials |
|